In this overview article, we’ll see how analysts are rating the leading steel stocks, and we’ll also compare performance from the top five steel companies.
What is the dividend outlook? Entergy Corporation’s (ETR) present dividend yield of 4.6% has been driven by dividend growth and price loss. Dividends grew 2% each in 2016 and 2017. The dividend is projected to grow 2% in 2018. What is the projected dividend payout? The company recorded a dividend payout of 48% in 2016. […]
Johnson & Johnson has launched a number of key products and has entered into some strategic partnerships and collaborations that have helped the company accelerate the growth of its medical device business.
Gilead Sciences’ (GILD) revenue fell 7% and 13% in 2016 and 9M17, respectively. The fall was due to lower product sales. Both antiviral products and other products recorded declines in both the periods.
In 3Q17, Eli Lilly’s (LLY) Cyramza generated revenues of $196 million, which reflected ~23% growth on a YoY basis and 5% growth on a quarter-over-quarter basis.
Microsoft’s (MSFT) 5.0% revenue growth in 2017 has been mainly driven by productivity and business processes and intelligent cloud, offset by more personal computing and other segments.
In 2Q17, Merck’s (MRK) Bridion generated revenues of ~$163 million, which reflected ~44% growth on a year-over-year basis and 10% growth on a quarter-over-quarter basis.
In this series, we’ll be looking at ten dividend aristocrats with low PE ratios. Dividend aristocrats are S&P 500 stocks that have raised their dividend payouts for at least 25 successive years.
The S&P 500 Dividend Aristocrat Index is made up of 51 S&P 500 (SPY) (SPX-INDEX) companies that have increased their dividends for 25 successive years.
Xgeva revenue trends In 2Q17, Amgen’s (AMGN) Xgeva generated revenues of ~$395 million, which reflected ~4% growth on a YoY (year-over-year) basis and a 2% decline on a QoQ (quarter-over-quarter) basis. In 2Q17, in the US, Xgeva generated revenues of ~$292 million, which reflected ~6% YoY growth and a ~2% QoQ decline. Outside the US, […]
The S&P 500 (SPY) defensive sectors tend to offer an attractive yield to investors during low-interest environments or when the economy is slowing down.
In 2016, AbbVie’s (ABBV) Viekira generated revenue of ~$1.5 billion, a fall of ~7% year-over-year (or YoY). In 1Q17, the drug reported revenue of ~$236 million.
On January 10, 2017, General Electric (GE) completed its acquisition of ServiceMax, a leader in cloud-based field service management solutions, for $915.0 million.
On January 28, Merck’s Zepatier secured approval from the FDA as a therapy for adult patients suffering from genotype 1 or genotype 4 HCV (Hepatitis C).
In his November Insights newsletter, Richard Bernstein stated, “It is incredible that investors have basically been wallflowers during the second longest bull market of the post-war period.”
Approximately 55% of the analysts tracking Patterson-UTI Energy rated it as a “buy,” ~26% rated it as a “hold,” and the other 19% rated it as a “sell.”
Domtar’s (UFS) net income and earnings per share fell to $18.0 million and $0.29, respectively, in 2Q16, compared with $38.0 million and $0.60, respectively, in 2Q15.
Price movement Domtar (UFS) has a market cap of $2.3 billion. It fell 1.4% to close at $36.97 per share on September 23, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 4.5%, -1.2%, and 2.3%, respectively, on the same day. UFS is trading 0.49% above its 20-day moving average, 0.73% below […]
In 1H16, Shell generated around $2.9 billion in cash from operations. It had cash outflows of $11.1 billion in the form of capex and $4.7 billion in the form of dividends.
Domtar has a market cap of $2.5 billion. It rose by 0.60% and closed at $38.45 per share on August 18. It reported 2Q16 consolidated sales of $1.27 billion.
In 1Q16, Total’s (TOT) cash flow from operations stood at $1.9 billion, around 57% lower than 1Q15. TOT’s cash outflow from investing stood at $3.9 billion in 1Q16 compared to $5.9 billion in 1Q15.
While discussing his views on the corporate profit cycle in the US with CNBC’s Michael Santoli, Richard Bernstein provided an interesting insight: The Market does not react to the absolutes of good or bad—it’s always better or worse.
Sinking oil prices have changed segment dynamics considerably for Petrobras (PBR). Its Exploration & Production segment reported a loss in 4Q15 due to impairments and lower crude oil prices.
Eni is insulated to a certain extent from oil price volatility due to its integrated model. However, the company is not immune to changes in oil prices.
Helmerich & Payne’s revenues have been in a downtrend from fiscal 2Q15 to fiscal 1Q16. In that period, its US Land Operations segment revenue declined 58%.
Looking at steel demand indicators, we see that construction activity has generally been strong in 2015, with spending in the United States exceeding $1 trillion for seven consecutive months.
In the previous part of this series, we saw that Seagate Technology’s (STX) lower-than-expected sales could give rival Western Digital (WDC) a competitive edge.
Present-day U.S. stock markets seem to have fully recovered from the recessionary abyss. Markets are reaching peaks higher than pre-crisis levels, with major indices such as the S&P 500 (SPY), Dow Jones (DIA) and NASDAQ (QQQ) surging to record highs.
Dividends pay returns even during market recovery. Major market indices like the S&P 500 (SPY), Dow Jones (DIA) and NASDAQ (QQQ) can be seen surging to record highs during a bubble.
The Fed’s policy of keeping the nominal interest rates at a zero lower bound leads some investors to seek higher and stabler income elsewhere. The low-interest rate regime may force risk-taking investors towards the higher-cost debt of high yield bonds.
Know the market and know your own appetite for risk before investing. You can’t eliminate market risk, also called systematic risk, through diversification. You can, however, hedge against market risk.
